Market Trends of Hydrocephalus Shunts Industry
Hydrocephalus Catheters are Expected to Hold a Significant Share in the Market During the Forecast Period
Hydrocephalus catheters are essential in managing hydrocephalus, and specific patient populations are at greater risk of developing shunt infections. These catheters are flexible tubes designed to carry excess cerebrospinal fluid (CSF) from the brain to another area of the body, allowing for absorption and alleviating pressure on the brain.
Advancements in catheters are expected to increase the adoption and propel the market's growth. For instance, in July 2023, the neurosurgeons at the Medical University of South California utilized the device ReFlow due to its ability to reverse the fluid flow within the catheter, which significantly decreased the number of follow-up surgeries needed for patients with hydrocephalus. Thus, increasing the use of such devices is anticipated to drive the segment's growth.
Furthermore, the research and developments by market players to expand the catheter solution are also expected to propel the segment’s growth. For instance, in May 2023, Anuncia Medical Inc. reported positive clinical trial outcome data using the ReFlow Ventricular System In-Line with Hydrocephalus Shunts. The ReFlow Ventricular System comprises an in-line flusher and a proprietary ventricular catheter. The rising research initiatives are expected to expand the availability of advanced hydrocephalus catheters in the upcoming years, accelerating the segment's growth.
Therefore, owing to the aforementioned factors, such as technological advancements and expansions by market players, the segment is expected to register a significant growth rate during the forecast period.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is expected to hold a significant share of the market due to factors such as the high burden of hydrocephalus, increased research and development (R&D) spending, product launches, approvals, and the high concentration of market players in the region.
The increasing prevalence of brain disorders is leading to a high demand for advanced shunts for treating hydrocephalus. For instance, the data published by the National Institute of Neurological Disorders and Stroke in July 2024 mentioned that one to two out of every 1,000 babies are born with hydrocephalus in the United States. Thus, the significant burden of hydrocephalus in the country is expected to increase the demand for hydrocephalus shunts, thereby boosting the market's growth during the forecast period.
Furthermore, neurosurgeons prefer the latest technology shunts, and the increasing adoption of technologically advanced shunts is expected to boost the market during the forecast period. For instance, in November 2023, surgeons at Intermountain Primary Children's Hospital in Utah, United States, successfully implanted a new brain shunt accessory with an Anuncia Medical implant called the ReFlow Mini Flusher designed for young patients suffering from hydrocephalus. The device has been demonstrated to remain in position more effectively and prevent clogging due to its design. Thus, such advanced hydrocephalus shunts are employed by surgeons and are expected to drive the market's growth in the region.
Moreover, in September 2023, researchers at Wayne State University specializing in hydrocephalus research were awarded a new round of National Institutes of Health (NIH) funding totaling USD 2.6 million to further advance their efforts in enhancing shunt design. The rising grants for developing innovative hydrocephalus shunts are expected to propel the market's growth in the region during the forecast period.
Therefore, owing to the above-mentioned factors, such as the high burden of hydrocephalus, rising R&D spending, and product approvals and launches by market players, the growth of the studied market is anticipated in North America.
